PROGRAM CHAIRS

Patricia Dugan, MD, FAES
Professor of Neurology (Clinical)
Director, Adult Epilepsy
Director, Epilepsy Fellowship Program
NYU Langone Health
Comprehensive Epilepsy Center
New York, New York

Sarah Kelley, MD
Associate Professor of Clinical Neurology
Director, Pediatric Epilepsy Monitoring Unit
Johns Hopkins School of Medicine
Baltimore, Maryland

Dana Price, MD
Clinical Assistant Professor
Department of Neurology
Grossman School of Medicine
New York University
New York, New York

PROGRAM OVERVIEW

This three-track educational program is designed to provide clinicians with knowledge and skills to address both immediate and long-term challenges in managing patients with developmental and epileptic encephalopathies (DEEs). Through a case-based approach, the program emphasizes accurate differentiation of DEE conditions based on clinical presentation, diagnostic assessment, imaging, and genetic evaluation. It also covers evidence-based treatment selection guided by established treatment algorithms and expert consensus, effective transitions from pediatric to adult care, and shared decision-making strategies to improve seizure outcomes for patients with DEEs.

TARGET AUDIENCE

This activity is tailored to address the educational needs of epileptologists, adult neurologists, and pediatric neurologists who provide care for pediatric and adult patients with epilepsy.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

• Utilize validated diagnostic tools and clinical assessments to enhance the accurate and timely diagnosis of DEEs
• Analyze the mechanism of action and clinical efficacy of cannabidiol in the treatment of DEEs
• Implement shared decision-making strategies to support patients with DEEs and their caregivers in making informed treatment choices
• Develop personalized care transition plans to ensure seamless progression from pediatric to adult care for individuals with DEEs

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

All relevant financial relationships have been mitigated.

Content Review

The content of this activity was independently peer reviewed by a physician and nurse reviewer.

Individuals in Control of the Content of the Activity

The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:

• Matthew Frese, MBA, CEO of Med Learning Group, has nothing to disclose.
• Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
• Chris Drury, MA, MS, MBA, Medical Director for Med Learning Group, has nothing to disclose.
• Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
• Daniel DaSilva, Accreditation and Outcomes Coordinator, has nothing to disclose.
• Nicolas Applyrs, Jr, DO, MS, MPH has nothing to disclose.
• Dominique Barton, BS, BSN has nothing to disclose.
• Brianna Hefele, PA-C has nothing to disclose.
• Sarah Milano RN, MSN has nothing to disclose.
• A medical reviewer from CME Peer Review LLC has nothing to disclose.
• Jessica McMullen, MPH, Program Director for Med Learning Group, has nothing to disclose.
• Savannah Barron, Program Coordinator for Med Learning Group, has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: July 17, 2025
EXPIRATION DATE: July 17, 2026